|
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan |
Flashes of Hope, McKenna Claire Foundation |
|
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University |
Tap Cancer Out |
|
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope, Tap Cancer Out |
|
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope, Tap Cancer Out |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
Platform development for target identification in high risk pediatric leukemias |
Columbia University, St. Jude Children’s Research Hospital |
The Brian Morden Foundation |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
Harmonizing Data Sharing Efforts towards a Federated Data Model |
University of California at Santa Cruz |
Pediatric Cancer Research Foundation |
|
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute |
Sammy’s Superheroes Foundation |
|
Overcoming Obstacles to Drug Development in Pediatric Cancer |
Stanford University School of Medicine |
Northwestern Mutual Foundation |
